BEVERLY HILLS, Calif., July 9 Worldwide Clinical Trials,Inc.("WCT"), formed by Dr. Neal R. Cutler and a team of scientists, todayreached a milestone in establishing itself as a premier global contractresearch organization with the announcement that it has closed the acquisitionof MediQuest, a contract research organization providing specialized clinicaldevelopment services to biopharmaceutical companies. The MediQuestacquisition was the most recent of five acquisitions made by WCT over the lastyear including Evidence Clinical and Pharmaceutical Research LLC, ClinicalStudies Management Group, Inc., Nottingham Clinical Research Limited and CEDRACorporation. The five acquisitions extend WCT's global footprint to more than30 countries.
WCT is a leading therapeutically focused contract research organizationthat applies deep therapeutic expertise to help customers achieve their drugdevelopment goals. WCT provides clinical consulting and Phase I-IV drugdevelopment services -- including clinical trial design, clinical operations,data management, biostatistics, medical affairs, safety/pharmacovigilance,Electronic Data Capture and Interactive Voice Response System technologies,regulatory affairs, quality assurance bioanalytical services (LC-MS-MS, ligandbinding, biomarkers), and pharmacokinetics -- for global pharma, specialtypharma and biotech companies.
Formed in 2007 by Dr. Cutler in partnership with The Jordan Company, aleading private equity firm, the company focuses on complex, high-growththerapeutic areas with primary expertise in central nervous system, andcardiovascular disease, along with significant experience in chronicinflammatory disease, metabolic / endocrinology and oncology. As expertise inthese areas continues to be in demand, Worldwide Clinical Trials has sought tobroaden its business through strategic growth and a highly selectiveacquisition strategy of companies that complements its existing skill-set.
"The acquisitions we have completed to date significantly enhance ourcontract research organization capabilities and our ability to manage large,global trials, within our primary therapeutic areas of focus. That in turnpositions us well for future growth," said Dr. Cutler. "We have effectivelyexpanded our operations and significantly enhanced our ability to meet theglobal needs of pharma and biotech companies. Our presence in Eastern Europeand Russia, two of the most attractive growth regions for clinical trials,helps transform our business into a truly global contract researchorganization."
Dr. Cutler and his team have reunited under the name of their formercompany, Worldwide Clinical Trials, which they founded in 1994 and sold toUnitedHealth in 1999. Dr. Cutler is known for pioneering severalrevolutionary techniques that increased the quality, safety and speed of drugdevelopment.
About Worldwide Clinical Trials, Inc.
Worldwide Clinical Trials (www.wwctrials.com) is a full-service contractresearch organization (CRO) that is medically and scientifically focused oncentral nervous system (CNS) and cardiovascular disease. WCT delivers qualityclinical trials with leading edge science and medicine to help clients thinkthrough design, methodology and regulatory issues that are unique to everydevelopment program. WCT provides highly focused CRO services in all phasesof research -- worldwide.
About The Jordan Company
The Jordan Company (www.thejordancompany.com), founded in 1982, is aleading middle-market private equity firm with over $6 billion of assets undermanagement and a successful track record of investing in and growingbusinesses across a wide range of industries. The firm's partners have beeninvesting together for more than two decades, establishing The Jordan Companyas one of the most experienced and stable investment teams in private equity.The investment team is supported by th